newsfilter
← Latest News
Business Wire·

AngioDynamics to Report Fiscal 2026 Second Quarter Results on January 6, 2026

AngioDynamics, Inc. (NASDAQ:ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient